Reduced-Dose Prasugrel Efficacious for Acute Coronary Syndrome

MONDAY, July 20, 2020 -- For elderly or low-weight patients with acute coronary syndrome (ACS), a reduced dose of prasugrel is efficacious compared with ticagrelor, according to a study published online July 21 in the Annals of Internal...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Study